The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease. 2018

N A Tmoyan, and M V Ezhov, and O I Afanasieva, and E A Klesareva, and O A Razova, and V V Kukharchuk, and S N Pokrovsky
A.L. Myasnikov Institute of Clinical Cardiology FSBI "National Medical Research Center of Cardiology" of MoH of Russia, Moscow, Russia.

OBJECTIVE Lipoprotein(a) [Lp(a)] is an independent risk factor of coronary heart disease (CHD) and myocardial infarction. Data about the role of Lp(a) in the development of peripheral artery disease (PAD) is controversial and uncertain. The aim of the study was to evaluate the association between Lp(a), apolipoprotein(a) [apo(a)] phenotypes and PAD. METHODS The study included 998 patients (707 male and 291 female, average age 60±12). The patients were divided into 4 groups depending on the presence or absence PAD and CHD: group I (n=188, PAD+CHD+), group II (n=78, PAD+CHD-), group III (n=407, PAD-CHD+), group IV (n=325, PAD-CHD-). RESULTS The level of Lp(a) was significantly higher in groups I, II, III in comparison with patients of control group (group IV): 34 [15; 80], 30 [10; 49], 22 [8; 60] mg/dl vs. 15 [6; 35] mg/dl respectively, p<0.01 in all cases. Lp(a) level was higher in the group I than in the other groups (p<0.05). The prevalence of elevated Lp(a) level (≥ 30 mg/dl) was significantly higher in groups I, II, III than in control group: 54%, 50%, 43% respectively vs. 30%, p<0.01 in all cases. The prevalence of Lp(a) ≥ 30 mg/dl was more frequent in the group with PAD and CHD than in the group with CHD and without PAD (p=0.02). The odds ratio (OR) of PAD in the presence of elevated Lp(a) level was 1.9 (95%CI, 1.4-2.5, p<0.01). Low molecular weight (LMW) apo(a) phenotype was met more frequently in groups I, II, III compared to group IV: 46%, 56%, 52% respectively vs. 28%, p<0.01. LMW apo(a) in the patients without CHD was associated with PAD (OR 3.3; 95% CI, 1.6-6.8, p<0.01), and there was no association with the patients with CHD. In logistic regression analysis adjusted for age, sex, hypertension, obesity, smoking, diabetes, LDL-C, Lp(a) and LMW apo(a) phenotype were independent predictors of PAD when included separately. CONCLUSIONS Elevated level of Lp(a) and LMW apo(a) phenotype are independent risk factors of PAD. The level of Lp(a) in the patients with PAD and CHD was higher than in the case of isolated lesion of each vascular pool. Higher level of Lp(a) is associated with more severe atherosclerosis involving more than one vascular pools.

UI MeSH Term Description Entries
D007120 Immunochemistry Field of chemistry that pertains to immunological phenomena and the study of chemical reactions related to antigen stimulation of tissues. It includes physicochemical interactions between antigens and antibodies.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078331 Correlation of Data Determination of whether or not two variables are correlated. This means to study whether an increase or decrease in one variable corresponds to an increase or decrease in the other variable. Correlation Studies,Correlation Study,Data Correlation,Data Correlations,Studies, Correlation,Study, Correlation
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

N A Tmoyan, and M V Ezhov, and O I Afanasieva, and E A Klesareva, and O A Razova, and V V Kukharchuk, and S N Pokrovsky
July 2014, Cardiovascular research,
N A Tmoyan, and M V Ezhov, and O I Afanasieva, and E A Klesareva, and O A Razova, and V V Kukharchuk, and S N Pokrovsky
March 1997, The Canadian journal of cardiology,
N A Tmoyan, and M V Ezhov, and O I Afanasieva, and E A Klesareva, and O A Razova, and V V Kukharchuk, and S N Pokrovsky
March 1997, Journal of hypertension,
N A Tmoyan, and M V Ezhov, and O I Afanasieva, and E A Klesareva, and O A Razova, and V V Kukharchuk, and S N Pokrovsky
July 2001, Diabetic medicine : a journal of the British Diabetic Association,
N A Tmoyan, and M V Ezhov, and O I Afanasieva, and E A Klesareva, and O A Razova, and V V Kukharchuk, and S N Pokrovsky
January 2011, Cardiology,
N A Tmoyan, and M V Ezhov, and O I Afanasieva, and E A Klesareva, and O A Razova, and V V Kukharchuk, and S N Pokrovsky
June 1994, Diabetologia,
N A Tmoyan, and M V Ezhov, and O I Afanasieva, and E A Klesareva, and O A Razova, and V V Kukharchuk, and S N Pokrovsky
October 1994, Arteriosclerosis and thrombosis : a journal of vascular biology,
N A Tmoyan, and M V Ezhov, and O I Afanasieva, and E A Klesareva, and O A Razova, and V V Kukharchuk, and S N Pokrovsky
January 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
N A Tmoyan, and M V Ezhov, and O I Afanasieva, and E A Klesareva, and O A Razova, and V V Kukharchuk, and S N Pokrovsky
July 2007, Clinical chemistry,
N A Tmoyan, and M V Ezhov, and O I Afanasieva, and E A Klesareva, and O A Razova, and V V Kukharchuk, and S N Pokrovsky
January 2000, Terapevticheskii arkhiv,
Copied contents to your clipboard!